Live from the NIH registry
Studies recruiting near Montgomery right now
Top 15 of 15 recruiting studies, sorted by proximity — each links to its official registry page
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
Asthma
Phase 3
Interventional 231 participants sought
Research Site — Montgomery, Alabama (2.3 mi)
· Sponsor: AstraZeneca
Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN)
Primary Membranous Nephropathy
Phase 2, Phase 3
Interventional 176 participants sought
Renal Associates — Montgomery, Alabama (2.3 mi)
· Sponsor: Vertex Pharmaceuticals Incorporated
Manipulation and Dry Needling in Patients With Cervicogenic Headache and WAD II
Cervicogenic Headache, Whiplash Injuries
N/A
Interventional 120 participants sought
Alabama Physical Therapy & Acupuncture — Montgomery, Alabama (2.3 mi)
· Sponsor: Alabama Physical Therapy & Acupuncture
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University Telemedicine — Montgomery, Alabama (2.3 mi)
· Sponsor: Sameek Roychowdhury
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Heart Failure
Phase 3
Interventional 4,200 participants sought
Drug Research and Analysis Corporation — Montgomery, Alabama (2.3 mi)
· Sponsor: Boehringer Ingelheim
A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease
Proteinuric Kidney Disease
Phase 2
Interventional 56 participants sought
Research Site — Montgomery, Alabama (2.3 mi)
· Sponsor: Maze Therapeutics
Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
Hidradenitis Suppurativa (HS)
Phase 3
Interventional 600 participants sought
Investigative Site US098 — Montgomery, Alabama (2.3 mi)
· Sponsor: Incyte Corporation
Characterization And Clinical Outcomes of AA Patients Treated With Ritlecitinib
Alopecia Areata
N/A
Observational 850 participants sought
C2 Research Center — Montgomery, Alabama (2.3 mi)
· Sponsor: Pfizer
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
Atopic Dermatitis
N/A
Observational 1,000 participants sought
River Region Dermatology and Laser- Site Number : 8400041 — Montgomery, Alabama (2.3 mi)
· Sponsor: Sanofi
Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease
Chronic Granulomatous Disease (CGD)
N/A
Observational 60 participants sought
Home-based telemedicine — Montgomery, Alabama (2.3 mi)
· Sponsor: Ensoma
Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease
Proteinuric Kidney Disease
Phase 2, Phase 3
Interventional 466 participants sought
Renal Associates of Alabama, LLC — Montgomery, Alabama (2.3 mi)
· Sponsor: Vertex Pharmaceuticals Incorporated
A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity
Obesity
Phase 2
Interventional 230 participants sought
Chambliss Clinical Trials, LLC — Montgomery, Alabama (2.3 mi)
· Sponsor: Novo Nordisk A/S
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
End Stage Kidney Disease
Phase 2, Phase 3
Interventional 3,110 participants sought
DaVita Clinical Research Montgomery — Montgomery, Alabama (2.3 mi)
· Sponsor: CSL Behring
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Kidney Disease
Phase 3
Interventional 347 participants sought
DCR Montgomery — Montgomery, Alabama (2.3 mi)
· Sponsor: Takeda
Evaluating an Interactive Digital Toolkit for Women's PrEP Implementation
HIV Prevention, HIV Risk
N/A
Interventional 125 participants sought
Five Horizons Health Services — Montgomery, Alabama (2.3 mi)
· Sponsor: University of Alabama at Birmingham